Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (571-580 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|January 27, 2018
Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathwayKevin Y Guo, Lili Han, Xinyu Li, et al.
Oncotarget|January 27, 2018
HDAC inhibition potentiates immunotherapy in triple negative breast cancerManuela Terranova-Barberio, Scott Thomas, Niwa Ali, et al.
Oncotarget|January 27, 2018
Insulin and novel thioglycosides exert suppressive effect on human breast and colon carcinoma cellsSiddarth Agrawal, Marta Wozniak, Mateusz Luc, et al.
Oncotarget|January 27, 2018
Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis childrenLin Sun, Biao Xie, Qiuju Zhang, et al.
Oncotarget|January 27, 2018
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitorsAdam Diehl, Mark Yarchoan, Alex Hopkins, et al.
Oncotarget|January 27, 2018
MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinomaZheng Lu, Zhou Nian, Zhang Jingjing, et al.
Oncotarget|January 27, 2018
Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basisTingting Xu, Lin Zhang, Hong Xu, et al.
Oncotarget|March 28, 2018
Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is moreHaris Zahoor, Brian I Rini, Moshe C Ornstein
Oncotarget|March 28, 2018
Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster modelYuko Iwata, Yoshimi Katayama, Yasushi Okuno, et al.
Oncotarget|March 28, 2018
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth <i>in vitro</i> and <i>in vivo</i>: a preliminary reportGiovani M Favero, Jessica L Paz, Andréia H Otake, et al.
Pageof 2,673

Showing results (571-580 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|January 27, 2018
Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathwayKevin Y Guo, Lili Han, Xinyu Li, et al.
Oncotarget|January 27, 2018
HDAC inhibition potentiates immunotherapy in triple negative breast cancerManuela Terranova-Barberio, Scott Thomas, Niwa Ali, et al.
Oncotarget|January 27, 2018
Insulin and novel thioglycosides exert suppressive effect on human breast and colon carcinoma cellsSiddarth Agrawal, Marta Wozniak, Mateusz Luc, et al.
Oncotarget|January 27, 2018
Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis childrenLin Sun, Biao Xie, Qiuju Zhang, et al.
Oncotarget|January 27, 2018
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitorsAdam Diehl, Mark Yarchoan, Alex Hopkins, et al.
Oncotarget|January 27, 2018
MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinomaZheng Lu, Zhou Nian, Zhang Jingjing, et al.
Oncotarget|January 27, 2018
Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basisTingting Xu, Lin Zhang, Hong Xu, et al.
Oncotarget|March 28, 2018
Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is moreHaris Zahoor, Brian I Rini, Moshe C Ornstein
Oncotarget|March 28, 2018
Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster modelYuko Iwata, Yoshimi Katayama, Yasushi Okuno, et al.
Oncotarget|March 28, 2018
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth <i>in vitro</i> and <i>in vivo</i>: a preliminary reportGiovani M Favero, Jessica L Paz, Andréia H Otake, et al.
Pageof 2,673